The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
Open accessAbstract
Aptamers are a class of small nucleic acid ligands that are composed of RNA or single-stranded DNA oligonucleotides and have high specificity and affinity for their targets. Similar to antibodies, aptamers interact with their targets by recognizing a specific three-dimensional structure and are thus termed "chemical antibodies." In contrast to protein antibodies, aptamers offer unique chemical and biological characteristics based on their oligonucleotide properties. Hence, they are more suitable for the development of novel clinical applications. Aptamer technology has been widely investigated in various biomedical fields for biomarker discovery, in vitro diagnosis, in vivo imaging, and targeted therapy. This review will discuss the potential applications of aptamer technology as a new tool for targeted cancer therapy with emphasis on the development of aptamers that are able to specifically target cell surface biomarkers. Additionally, we will describe several approaches for the use of aptamers in targeted therapeutics, including aptamer-drug conjugation, aptamer-nanoparticle conjugation, aptamer-mediated targeted gene therapy, aptamer-mediated immunotherapy, and aptamer-mediated biotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase
Cerchia, L., Ducongé, F., Pestourie, C., Boulay, J., Aissouni, Y., Gombert, K., Tavitian, B., de Franciscis, V., & Libri, D. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030123 · Cited by 246
RetractedDifferential SELEX in Human Glioma Cell Lines
Cerchia, L., Esposito, C. L., Jacobs, A. H., Tavitian, B., & de Franciscis, V. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007971 · Cited by 65
RetractedTuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
In vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015004 · Cited by 1,754
Yıldırım, M. A., Goh, K.-I., Cusick, M. E., Barabási, A.-L., & Vidal, M. (2007) · Nature Biotechnology · doi:10.1038/nbt1338 · Cited by 1,708
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Aptamers evolved from live cells as effective molecular probes for cancer study
Shangguan, D., Li, Y., Tang, Z., Cao, Z. C., Chen, H. W., Mallikaratchy, P., Sefah, K., Yang, C. J., & Tan, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602615103 · Cited by 1,516
Self-citationCell type–specific delivery of siRNAs with aptamer-siRNA chimeras
McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,002
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Aptamers: An Emerging Class of Therapeutics
Nimjee, S. M., Rusconi, C. P., & Sullenger, B. A. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.062904.144915 · Cited by 937
Development of DNA aptamers using Cell-SELEX
Sefah, K., Shangguan, D., Xiong, X., O'Donoghue, M. B., & Tan, W. (2010) · Nature Protocols · doi:10.1038/nprot.2010.66 · Cited by 918
Self-citationNanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
Aptamers and Their Biological Applications
Song, K.-M., Lee, S., & Ban, C. (2012) · Sensors · doi:10.3390/s120100612 · Cited by 821
An Aptamer–Doxorubicin Physical Conjugate as a Novel Targeted Drug‐Delivery Platform
Bagalkot, V., Farokhzad, O. C., Langer, R., & Jon, S. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602251 · Cited by 613
Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery
Guo, J., Gao, X., Su, L., Xia, H., Gu, G., Pang, Z., Jiang, X., Yao, L., Chen, J., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.004 · Cited by 566
Lupold, S. E., Hicke, B. J., Lin, Y. H., & Coffey, D. S. (2002) · PubMed · Cited by 566
Zhu, G., Zheng, J., Song, E., Donovan, M., Zhang, K., Liu, C., & Tan, W. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220817110 · Cited by 546
Self-citationSong, Y., Zhu, Z., An, Y., Zhang, W., Zhang, H., Liu, D., Yu, C., Duan, W., & Yang, C. J. (2013) · Analytical Chemistry · doi:10.1021/ac400366b · Cited by 525
Dhar, S., Kolishetti, N., Lippard, S. J., & Farokhzad, O. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011379108 · Cited by 513
Discovery and development of anticancer aptamers
Ireson, C. R., & Kelland, L. R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0172 · Cited by 481
Selection of Aptamers for Molecular Recognition and Characterization of Cancer Cells
Tang, Z., Shangguan, D., Wang, K., Shi, H., Sefah, K., Mallikratchy, P., Chen, H. W., Li, Y., & Tan, W. (2007) · Analytical Chemistry · doi:10.1021/ac070189y · Cited by 479
Self-citationCell-Specific Aptamer Probes for Membrane Protein Elucidation in Cancer Cells
Shangguan, D., Cao, Z., Meng, L., Mallikaratchy, P., Sefah, K., Wang, H., Li, Y., & Tan, W. (2008) · Journal of Proteome Research · doi:10.1021/pr700894d · Cited by 465
Self-citationAptamer mediated siRNA delivery
Chu, T. C. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl388 · Cited by 446
Molecular Assembly of an Aptamer–Drug Conjugate for Targeted Drug Delivery to Tumor Cells
Huang, Y., Shangguan, D., Liu, H., Phillips, J. A., Zhang, X., Chen, Y., & Tan, W. (2009) · ChemBioChem · doi:10.1002/cbic.200800805 · Cited by 422
Self-citationTHE EYETECH STUDY GROUP (2002) · Retina · doi:10.1097/00006982-200204000-00002 · Cited by 415
Ferreira, C. S. M., Matthews, C. S., & Missailidis, S. (2006) · Tumor Biology · doi:10.1159/000096085 · Cited by 407
Gopinath, S. C. B. (2007) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-006-0826-2 · Cited by 392
DNA aptamer–micelle as an efficient detection/delivery vehicle toward cancer cells
Wu, Y., Sefah, K., Liu, H., Wang, R., & Tan, W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909611107 · Cited by 330
Self-citationTenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein
Hicke, B. J., Marion, C., Chang, Y.-F., Gould, T., Lynott, C. K., Parma, D., Schmidt, P. G., & Warren, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104651200 · Cited by 324
Aptamer-Based Sensor Arrays for the Detection and Quantitation of Proteins
Kirby, R., Cho, E. J., Gehrke, B., Bayer, T., Park, Y. S., Neikirk, D. P., McDevitt, J. T., & Ellington, A. D. (2004) · Analytical Chemistry · doi:10.1021/ac049858n · Cited by 313
Kraemer, S., Vaught, J. D., Bock, C., Gold, L., Katilius, E., Keeney, T. R., Kim, N., Saccomano, N. A., Wilcox, S. K., Zichi, D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026332 · Cited by 310
Novel Dual Inhibitory Function Aptamer–siRNA Delivery System for HIV-1 Therapy
Zhou, J., Li, H., Li, S., Zaia, J., & Rossi, J. J. (2008) · Molecular Therapy · doi:10.1038/mt.2008.92 · Cited by 301
Aptamer-Based Tumor-Targeted Drug Delivery for Photodynamic Therapy
Shieh, Y.-A., Yang, S.-J., Wei, M.-F., & Shieh, M.-J. (2010) · ACS Nano · doi:10.1021/nn901374b · Cited by 299
Application of locked nucleic acids to improve aptamer in vivo stability and targeting function
Schmidt, K. S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh862 · Cited by 287
SELEX with modified nucleotides
Keefe, A. D., & Cload, S. T. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.06.028 · Cited by 283
In vivo selection of tumor-targeting RNA motifs
Mi, J., Liu, Y., Rabbani, Z. N., Yang, Z., Urban, J. H., Sullenger, B. A., & Clary, B. M. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.277 · Cited by 269
Mallikaratchy, P., Tang, Z., Kwame, S., Meng, L., Shangguan, D., & Tan, W. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700026-mcp200 · Cited by 268
Self-citationZhou, J., Swiderski, P., Li, H., Zhang, J., Neff, C. P., Akkina, R., & Rossi, J. J. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp185 · Cited by 267
Neff, C. P., Zhou, J., Remling, L., Kuruvilla, J., Zhang, J., Li, H., Smith, D. D., Swiderski, P., Rossi, J. J., & Akkina, R. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001581 · Cited by 259
Therapeutic RNA aptamers in clinical trials
Sundaram, P., Kurniawan, H., Byrne, M. E., & Wower, J. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.10.014 · Cited by 259
Molecular Recognition of Small‐Cell Lung Cancer Cells Using Aptamers
Chen, H. W., Medley, C. D., Sefah, K., Shangguan, D., Tang, Z., Meng, L., Smith, J. E., & Tan, W. (2008) · ChemMedChem · doi:10.1002/cmdc.200800030 · Cited by 250
Self-citationRNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule
Shigdar, S., Lin, J., Yu, Y., Pastuovic, M., Wei, M., & Duan, W. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01897.x · Cited by 240
Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures
Mayer, G., Ahmed, M.-S. L., Dolf, A., Endl, E., Knolle, P. A., & Famulok, M. (2010) · Nature Protocols · doi:10.1038/nprot.2010.163 · Cited by 231
Gene therapy progress and prospects: RNA aptamers
Que-Gewirth, N. S., & Sullenger, B. A. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302900 · Cited by 227
Molecular recognition of acute myeloid leukemia using aptamers
Sefah, K., Tang, Z. W., Shangguan, D. H., Chen, H., Lopez-Colon, D., Li, Y., Parekh, P., Martin, J., Meng, L., Phillips, J. A., et al. (2009) · Leukemia · doi:10.1038/leu.2008.335 · Cited by 226
Self-citationAptamer-conjugated nanomaterials and their applications
Yang, L., Zhang, X., Ye, M., Jiang, J., Yang, R., Fu, T., Chen, Y., Wang, K., Liu, C., & Tan, W. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.002 · Cited by 226
Self-citationViral Capsid DNA Aptamer Conjugates as Multivalent Cell-Targeting Vehicles
Tong, G. J., Hsiao, S. C., Carrico, Z. M., & Francis, M. B. (2009) · Journal of the American Chemical Society · doi:10.1021/ja903857f · Cited by 224
Xu, W., Siddiqui, I. A., Nihal, M., Pilla, S., Rosenthal, K., Mukhtar, H., & Gong, S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.006 · Cited by 223
In vivo SELEX for Identification of Brain-penetrating Aptamers
Cheng, C., Chen, Y. H., Lennox, K. A., Behlke, M. A., & Davidson, B. L. (2013) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2012.59 · Cited by 214
Phototoxic aptamers selectively enter and kill epithelial cancer cells
Ferreira, C. S. M., Cheung, M. C., Missailidis, S., Bisland, S., & Gariépy, J. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn967 · Cited by 212
Inhibition of Cell Proliferation by an Anti-EGFR Aptamer
Li, N., Nguyen, H. H., Byrom, M., & Ellington, A. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020299 · Cited by 205
Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers
Thiel, K. W., Hernandez, L. I., Dassie, J. P., Thiel, W. H., Liu, X., Stockdale, K. R., Rothman, A. M., Hernandez, F. J., McNamara, J. O., & Giangrande, P. H. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks294 · Cited by 202
Xing, H., Tang, L., Yang, X., Hwang, K., Wang, W., Yin, Q., Wong, N. Y., Dobrucki, L. W., Yasui, N., Katzenellenbogen, J. A., et al. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb20412j · Cited by 199
Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro
Liu, Z., Duan, J.-H., Song, Y.-M., Ma, J., Wang, F.-D., Lu, X., & Yang, X.-D. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-148 · Cited by 193
AS1411 aptamer tagged PLGA‐lecithin‐PEG nanoparticles for tumor cell targeting and drug delivery
Aravind, A., Jeyamohan, P., Nair, R., Veeranarayanan, S., Nagaoka, Y., Yoshida, Y., Maekawa, T., & Kumar, D. S. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24558 · Cited by 191
Chen, C.-H. B., Chernis, G. A., Hoang, V. Q., & Landgraf, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332660100 · Cited by 190
Yu, C., Hu, Y., Duan, J., Yuan, W., Wang, C., Xu, H., & Yang, X.-D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024077 · Cited by 190
A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death
Esposito, C. L., Passaro, D., Longobardo, I., Condorelli, G., Marotta, P., Affuso, A., de Franciscis, V., & Cerchia, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024071 · Cited by 182
Spiegelmers: Biostable Aptamers
Eulberg, D., & Klussmann, S. (2003) · ChemBioChem · doi:10.1002/cbic.200300663 · Cited by 181
Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells
Zhao, Z., Xu, L., Shi, X., Tan, W., Fang, X., & Shangguan, D. (2009) · The Analyst · doi:10.1039/b904476k · Cited by 179
Self-citationRNA aptamers targeting cancer stem cell marker CD133
Shigdar, S., Qiao, L., Zhou, S.-F., Xiang, D., Wang, T., Li, Y., Lim, L. Y., Kong, L., Li, L., & Duan, W. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.11.032 · Cited by 174
Aptamer-Mediated Blockade of IL4Rα Triggers Apoptosis of MDSCs and Limits Tumor Progression
Roth, F., De La Fuente, A. C., Vella, J. L., Zoso, A., Inverardi, L., & Serafini, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2772 · Cited by 173
Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth
Mahlknecht, G., Maron, R., Mancini, M., Schechter, B., Sela, M., & Yarden, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302594110 · Cited by 169
Bi-specific Aptamers Mediating Tumor Cell Lysis
Boltz, A., Piater, B., Toleikis, L., Guenther, R., Kolmar, H., & Hock, B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.238261 · Cited by 165
DNA Aptamer‐Mediated Cell Targeting
Xiong, X., Liu, H., Zhao, Z., Altman, M. B., Lopez‐Colon, D., Yang, C. J., Chang, L., Liu, C., & Tan, W. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201207063 · Cited by 164
Self-citationIdentification of an aptamer targeting hnRNP A1 by tissue slide‐based SELEX
Li, S., Xu, H., Ding, H., Huang, Y., Cao, X., Yang, G., Li, J., Xie, Z., Meng, Y., Li, X., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2543 · Cited by 161
Kim, E., Jung, Y., Choi, H., Yang, J., Suh, J., Huh, Y., Kim, K., & Haam, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.030 · Cited by 157
Targeting Axl With an High-affinity Inhibitory Aptamer
Cerchia, L., Esposito, C. L., Camorani, S., Rienzo, A., Stasio, L., Insabato, L., Affuso, A., & de Franciscis, V. (2012) · Molecular Therapy · doi:10.1038/mt.2012.163 · Cited by 155
Novel MUC1 Aptamer Selectively Delivers Cytotoxic Agent to Cancer Cells In Vitro
Hu, Y., Duan, J., Zhan, Q., Wang, F., Lu, X., & Yang, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031970 · Cited by 149
Jalalian, S. H., Taghdisi, S. M., Hamedani, N. S., Moosavian, S. A., Lavaee, P., Zandkarimi, M., Ghows, N., Jaafari, M. R., Naghibi, S., Danesh, N. M., et al. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.06.015 · Cited by 147
Wu, S. Y., Yang, X., Gharpure, K. M., Hatakeyama, H., Egli, M., McGuire, M. H., Nagaraja, A. S., Miyake, T. M., Rupaimoole, R., Pecot, C. V., et al. (2014) · Nature Communications · doi:10.1038/ncomms4459 · Cited by 146
A polyvalent aptamer system for targeted drug delivery
Zhang, Z., Ali, M. M., Eckert, M. A., Kang, D., Chen, Y. Y., Sender, L. S., Fruman, D. A., & Zhao, W. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.079 · Cited by 146
Current Progress of RNA Aptamer-Based Therapeutics
Zhou, J., Bobbin, M. L., Burnett, J., & Rossi, J. J. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00234 · Cited by 143
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFRβ Aptamer
Camorani, S., Esposito, C. L., Rienzo, A., Catuogno, S., Iaboni, M., Condorelli, G., de Franciscis, V., & Cerchia, L. (2014) · Molecular Therapy · doi:10.1038/mt.2013.300 · Cited by 140
An RNA Alternative to Human Transferrin: A New Tool for Targeting Human Cells
Wilner, S. E., Wengerter, B. C., Maier, K. E., Magalhães, M. D. L. B., del Amo, D. S., Pai, S., Opazo, F., Rizzoli, S. O., Yan, A. C., & Levy, M. (2012) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2012.14 · Cited by 139
Generating Aptamers for Recognition of Virus-Infected Cells
Tang, Z., Parekh, P. A., Turner, P., Moyer, R. W., & Tan, W. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.113514 · Cited by 139
Self-citationDual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and PSMA (−) prostate cancers
Min, K., Jo, H., Song, K.-M., Cho, M., Chun, Y., Jon, S., Kim, W. J., & Ban, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.035 · Cited by 137
CD28 Aptamers as Powerful Immune Response Modulators
Pastor, F., Soldevilla, M. M., Villanueva, H., Kolonias, D. S., Inogés, S., de Cerio, A. L.-D., Kandzia, R., Klimyuk, V. I., Gleba, Y. Y., Gilboa, E., et al. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.26 · Cited by 126
E‐Selectin‐Targeted Porous Silicon Particle for Nanoparticle Delivery to the Bone Marrow
Mann, A. P., Tanaka, T., Somasunderam, A., Liu, X., Gorenstein, D. G., & Mauro Ferrari, B. (2011) · Advanced Materials · doi:10.1002/adma.201101541 · Cited by 125
In Vitro Selection of DNA Aptamers to Glioblastoma Multiforme
Bayraç, A. T., Sefah, K., Parekh, P. A., Bayraç, C., Gülbakan, B., Öktem, H. A., & Tan, W. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn100114k · Cited by 119
Self-citationPhotosensitizer–Gold Nanorod Composite for Targeted Multimodal Therapy
Wang, J., You, M., Zhu, G., Shukoor, M. I., Chen, Z., Zhao, Z., Altman, M. O., Yuan, Q., Zhu, Z., Chen, Y., et al. (2013) · Small · doi:10.1002/smll.201202155 · Cited by 119
Self-citationQuantitative selection and parallel characterization of aptamers
Cho, M., Oh, S. S., Nie, J., Stewart, R. M., Eisenstein, M. S., Chambers, J., Marth, J. D., Walker, F. M., Thomson, J. A., & Soh, H. T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315866110 · Cited by 116
Thiel, W. H., Bair, T., Peek, A. S., Liu, X., Dassie, J. P., Stockdale, K. R., Behlke, M. A., Miller, F. J., & Giangrande, P. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043836 · Cited by 114
Saifer, M. G. P., Williams, L. D., Sobczyk, M. A., Michaels, S. J., & Sherman, M. R. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.07.014 · Cited by 112
DNA Aptamers as Molecular Probes for Colorectal Cancer Study
Sefah, K., Meng, L. H., López‐Colón, D., Jiménez, E., Liu, C., & Tan, W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014269 · Cited by 110
Self-citationStudy of the Molecular Recognition of Aptamers Selected through Ovarian Cancer Cell-SELEX
Simaeys, D. V., López‐Colón, D., Sefah, K., Sutphen, R., Jiménez, E., & Tan, W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013770 · Cited by 108
Self-citationMann, A. P., Somasunderam, A., Nieves-Alicea, R., Li, X., Hu, A. H., Sood, A. K., Mauro Ferrari, B., Gorenstein, D. G., & Tanaka, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013050 · Cited by 106
Bagalkot, V., & Gao, X. (2011) · ACS Nano · doi:10.1021/nn202772p · Cited by 104
Combinatorial Selection of DNA Thioaptamers Targeted to the HA Binding Domain of Human CD44
Somasunderam, A., Thiviyanathan, V., Tanaka, T., Li, X., Neerathilingam, M., Lokesh, G. L.-R., Mann, A. P., Peng, Y., Mauro Ferrari, B., Klostergaard, J., et al. (2010) · Biochemistry · doi:10.1021/bi1009503 · Cited by 103
Alkaline Phosphatase ALPPL-2 Is a Novel Pancreatic Carcinoma-Associated Protein
Dua, P., Kang, H. S., Hong, S., Tsao, M., Kim, S., & Lee, D.-K. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3682 · Cited by 98
Zhao, N., Bagaria, H. G., Wong, M. S., & Zu, Y. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-2 · Cited by 97
Self-citationA Novel Aptamer Developed for Breast Cancer Cell Internalization
Zhang, K., Sefah, K., Tang, L., Zhao, Z., Zhu, G., Ye, M., Sun, W., Steve Goodison, B., & Tan, W. (2011) · ChemMedChem · doi:10.1002/cmdc.201100457 · Cited by 93
Self-citationBoyacıoğlu, O., Stuart, C. H., Kulik, G., & Gmeiner, W. H. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.37 · Cited by 92
Thioaptamer Conjugated Liposomes for Tumor Vasculature Targeting
Mann, A. P., Bhavane, R. C., Somasunderam, A., Montalvo-Ortiz, B. L., Ghaghada, K. B., Volk, D. E., Nieves-Alicea, R., Suh, K. S., Mauro Ferrari, B., Annapragada, A., et al. (2010) · Oncotarget · doi:10.18632/oncotarget.261 · Cited by 91
In Vitro Selection of RNA Aptamer and Specific Targeting of ErbB2 in Breast Cancer Cells
Kim, M. Y., & Jeong, S. (2011) · Nucleic Acid Therapeutics · doi:10.1089/nat.2011.0283 · Cited by 89
Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer
Parekh, P. A., Kamble, S., Zhao, N., Zeng, Z., Portier, B. P., & Zu, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.099 · Cited by 80
Self-citationTan, L., Neoh, K. G., Kang, E. T., Choe, W. S., & Su, X. (2011) · Macromolecular Bioscience · doi:10.1002/mabi.201100173 · Cited by 80
Mori, T. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh949 · Cited by 78
Dai, F., Zhang, Y., Zhu, X., Shan, N., & Chen, Y. (2012) · Targeted Oncology · doi:10.1007/s11523-012-0236-7 · Cited by 77
Self-citationIn Vitro Selection of Modified RNA Aptamers Against CD44 Cancer Stem Cell Marker
Ababneh, N. A., Alshaer, W., Al‐Louzi, O., Mahafzah, A. M., El-Khateeb, M. S., Hillaireau, H., Noiray, M., Fattal, E., & Ismail, S. I. (2013) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0423 · Cited by 76
Immunofluorescence assay and flow-cytometry selection of bead-bound aptamers
Yang, X. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng054 · Cited by 76
Aptamer-Mediated Delivery of Chemotherapy to Pancreatic Cancer Cells
Ray, P., Cheek, M. A., Sharaf, M. L., Li, N., Ellington, A. D., Sullenger, B. A., Shaw, B. R., & White, R. R. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0353 · Cited by 76
Zhou, J., Tiemann, K., Chomchan, P., Alluin, J. V., Swiderski, P. M., Burnett, J., Zhang, X., Forman, S. J., Chen, R., & Rossi, J. J. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt125 · Cited by 75
Mi, J., Zhang, X., Giangrande, P. H., McNamara, J. O., Nimjee, S. M., Sarraf‐Yazdi, S., Sullenger, B. A., & Clary, B. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.043 · Cited by 74
Yang, X. (2002) · Nucleic Acids Research · doi:10.1093/nar/gnf132 · Cited by 74
Selection of DNA ligands for protein kinase C-?
Mallikaratchy, P. R., Stahelin, R. V., Cao, Z. C., Cho, W., & Tan, W. (2006) · Chemical Communications · doi:10.1039/b604778e · Cited by 72
Self-citationWang, F., Rong, Y., Fang, M., Yuan, J., Peng, C., Liu, S., & Li, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.018 · Cited by 70
Parekh, P. A., Tang, Z., Turner, P., Moyer, R. W., & Tan, W. (2010) · Analytical Chemistry · doi:10.1021/ac101801j · Cited by 68
Self-citationLee, Y. J., Han, S. R., Kim, N. Y., Lee, S., Jeong, J., & Lee, S. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.039 · Cited by 67
Self‐Assembled Aptamer‐Based Drug Carriers for Bispecific Cytotoxicity to Cancer Cells
Zhu, G., Meng, L. H., Ye, M., Yang, L. S., Sefah, K., O’Donoghue, M. B., Chen, Y., Xiong, X., Huang, J. L., Song, E., et al. (2012) · Chemistry - An Asian Journal · doi:10.1002/asia.201101060 · Cited by 66
Self-citationSelection of DNA Aptamers against Glioblastoma Cells with High Affinity and Specificity
Kang, D., Wang, J., Zhang, W., Song, Y., Li, X., Zou, Y. W., Zhu, M., Zhu, Z., Chen, F., & Yang, C. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042731 · Cited by 66
Selection of Aptamers Specific for Adipose Tissue
Liu, J., Liu, H., Sefah, K., Liu, B., Pu, Y. D., Simaeys, D. V., & Tan, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037789 · Cited by 55
Self-citationLiu, J., Liu, H., Kang, H., Donovan, M., Zhu, Z., & Tan, W. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-5414-4 · Cited by 54
Self-citationCell‐based selection provides novel molecular probes for cancer stem cells
Sefah, K., Bae, K., Phillips, J. A., Siemann, D. W., Su, Z. Z., McClellan, S., Vieweg, J., & Tan, W. (2012) · International Journal of Cancer · doi:10.1002/ijc.27936 · Cited by 52
Self-citation99mTc-MAG3-Aptamer for Imaging Human Tumors Associated with High Level of Matrix Metalloprotease-9
Gomes, S. D. R., Miguel, J., Azéma, L., Eimer, S., Ries, C., Dausse, E., Loiseau, H., Michèle Allard, A., & Toulmé, J. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300146c · Cited by 48
The anti-chemoresistant effect and mechanism of MUC1 aptamer–miR-29b chimera in ovarian cancer
Dai, F., Zhang, Y., Zhu, X., Shan, N., & Chen, Y. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.07.112 · Cited by 47
Self-citationAvci‐Adali, M., Metzger, M., Perle, N., Ziemer, G., & Wendel, H. P. (2010) · Oligonucleotides · doi:10.1089/oli.2010.0253 · Cited by 46
Dastjerdi, K., Tabar, G. H., Dehghani, H., & Haghparast, A. (2011) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.36 · Cited by 42
Gourronc, F. A., Rockey, W. M., Thiel, W. H., Giangrande, P. H., & Klingelhutz, A. J. (2013) · Virology · doi:10.1016/j.virol.2013.08.015 · Cited by 41
Targeted in vitro photodynamic therapy via aptamer-labeled, porphyrin-loaded virus capsids
Cohen, B. A., & Bergkvist, M. (2013) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2013.02.013 · Cited by 40
Targeted delivery of Epirubicin to cancer cells by PEGylated A10 aptamer
Taghdisi, S. M., Danesh, N. M., Emrani, A. S., Tabrizian, K., Zandkarimi, M., Ramezani, M., & Abnous, K. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.812095 · Cited by 40
Properties of an ‘LNA’-modified ricin RNA aptamer
Förster, C., Zydek, M., Rothkegel, M., Wu, Z., Gallin, C., Gessner, R. V., Lisdat, F., & Fürste, J. P. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.127 · Cited by 34
Application of Aptamers for Targeted Therapeutics
Ray, P., Viles, K. D., Soule, E. E., & Woodruff, R. S. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0227-0 · Cited by 32
Cell Internalization SELEX: In Vitro Selection for Molecules That Internalize into Cells
Yan, A. C., & Levy, M. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-730-3_18 · Cited by 31
Waybrant, B., Pearce, T. R., Wang, P., Sreevatsan, S., & Kokkoli, E. (2012) · Chemical Communications · doi:10.1039/c2cc34217k · Cited by 26
Ray, P., Sullenger, B. A., & White, R. R. (2013) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0439 · Cited by 23
Cited by
Contrast agents for molecular photoacoustic imaging
Weber, J., Beard, P. C., & Bohndiek, S. E. (2016) · Nature Methods · doi:10.1038/nmeth.3929 · Cited by 1,270
Chemistry, structure and function of approved oligonucleotide therapeutics
Egli, M., & Manoharan, M. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad067 · Cited by 828
DNA Functional Materials Assembled from Branched DNA: Design, Synthesis, and Applications
Dong, Y., Yao, C., Zhu, Y., Yang, L., Luo, D., & Yang, D. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00294 · Cited by 533
The Medicinal Chemistry of Therapeutic Oligonucleotides
Wan, W. B., & Seth, P. P. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00551 · Cited by 429
Optochemical Control of Biological Processes in Cells and Animals
Ankenbruck, N., Courtney, T., Naro, Y., & Deiters, A. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201700171 · Cited by 419
Metadata
- Authors
- Sun, H., Zhu, X., Lu, P. Y., Rosato, R. R., Tan, W., & Zu, Y.
- Venue
- Molecular Therapy - Nucleic Acids
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 3
- Pages
- e182
- ISSN
- 2162-2531 (ISSN-L)
- OpenAlex
- W2002089022
- Cited by
- 541
- References
- 129
- FWCI
- 20.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.